Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
Citi
Teva
Deloitte
Queensland Health

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,744,582

« Back to Dashboard

Which drugs does patent 7,744,582 protect, and when does it expire?

Patent 7,744,582 protects OTREXUP and is included in one NDA.

This patent has thirteen patent family members in eight countries.

Summary for Patent: 7,744,582
Title:Needle assisted jet injector
Abstract: A needle assisted jet injector and method for jet injecting medicament are disclosed. In one embodiment of the injector, the needle is retractably located within an injector nozzle assembly. Upon activation of the force generating source, a portion of the needle extends past the nozzle assembly and penetrates the outer layer of skin to deliver the medicament via jet injection to a deeper region. After activation, the needle retracts back into the nozzle assembly. In another embodiment, the needle is fixed to the end of the nozzle assembly. In both embodiments, the length of the portion of the needle that penetrates the skin is less than 5 mm.
Inventor(s): Sadowski; Peter L. (Woodbury, MN), Deboer; David M. (Brighton, MI), Berman; Claude L. (Ypsilanti, MI), Lesch, Jr.; Paul R. (Lexington, MN), Holland; Margaret L. (Rochester, NY)
Assignee: Antares Pharma, Inc. (Minneapolis, MN)
Application Number:10/861,429
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,744,582
Patent Claim Types:
see list of patent claims
Use; Device; Delivery;

Drugs Protected by US Patent 7,744,582

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-001 Oct 11, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y SUBCUTANEOUS INJECTION OF METHOTREXATE ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-002 Oct 11, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y SUBCUTANEOUS INJECTION OF METHOTREXATE ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-003 Oct 11, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y SUBCUTANEOUS INJECTION OF METHOTREXATE ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-004 Oct 11, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y SUBCUTANEOUS INJECTION OF METHOTREXATE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 7,744,582

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 240756 ➤ Sign Up
Austria 281195 ➤ Sign Up
Australia 5470499 ➤ Sign Up
China 1212867 ➤ Sign Up
China 1323230 ➤ Sign Up
Germany 69908140 ➤ Sign Up
Germany 69921704 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
QuintilesIMS
Julphar
Fish and Richardson
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.